Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Share-based Compensation (2010 - 2026)

Talphera (TLPH) posted Share-based Compensation of $4.2 million for Q2 2026, up 5.29% on a QoQ basis from $4.0 million in Q1 2026, and up 71.43% year-over-year from $2.5 million in Q2 2025.

Analysis

Talphera (TLPH) Share-based Compensation (2010 - 2026) Analysis & Trends

Talphera has reported Share-based Compensation for 17 years, with the latest figure at $4.2 million in Q2 2026.

  • On a quarterly basis, Share-based Compensation rose 71.43% year-over-year to $4.2 million in Q2 2026; TTM through Jun 2026 was $4.2 million, a 71.43% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 46.09% from the prior year.
  • Share-based Compensation was $4.2 million for Q2 2026 at Talphera, up from $4.0 million in the prior quarter.
  • The five-year high for Share-based Compensation was $15.6 million in Q1 2022, with the low at -$563000.0 in Q4 2024.
  • Average Share-based Compensation over 5 years is $3.0 million, with a median of $1.7 million recorded in 2024.
  • The sharpest annual moves came in 2024 and 2026: Share-based Compensation tumbled 281.03% in 2024, then surged 125.08% in 2026.
  • Over 5 years, Share-based Compensation stood at $652000.0 in 2022, then plunged by 52.3% to $311000.0 in 2023, then sank by 281.03% to -$563000.0 in 2024, then jumped by 46.71% to -$300000.0 in 2025, then surged by 1505.31% to $4.2 million in 2026.
  • The last three Share-based Compensation figures came in at $4.2 million (Q2 2026), $4.0 million (Q1 2026), and -$300000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 243.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 120.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 86.63 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 77.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 83.34 Mn
10 Talphera 92.90 Mn 92.90 Mn - 4.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.22 Mn
Mar 31, 2026 4.00 Mn
Dec 31, 2025 -300,000.00
Sep 30, 2025 2.44 Mn
Jun 30, 2025 2.46 Mn
Mar 31, 2025 1.78 Mn
Dec 31, 2024 -563,000.00
Sep 30, 2024 1.88 Mn
Jun 30, 2024 1.93 Mn
Mar 31, 2024 1.67 Mn
Dec 31, 2023 311,000.00
Sep 30, 2023 875,332.00
Jun 30, 2023 885,783.00
Mar 31, 2023 897,391.00
Dec 31, 2022 652,000.00
Sep 30, 2022 733,308.00
Jun 30, 2022 15.04 Mn
Mar 31, 2022 15.64 Mn
Dec 31, 2021 1.19 Mn
Sep 30, 2021 14.38 Mn